S100P通过PKA/c-Jun介导的瘤相关的巨细胞招募和两极化促进LUAD的进展
Lu Gao1, Ying Bai1, Jiawei Zhou1
1School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China; Anhui Occupational Health and Safety Engineering Laboratory, Huainan, Anhui, China.
Cellular signalling
|April 19, 2024
概括
通过PKA/c-Jun通路,S100P蛋白通过招募M2瘤相关巨细胞 (TAMs) 来促进肺腺癌的生长. 这突出了S100P作为潜在的诊断标记物和LUAD的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- S100P蛋白与癌症进展有关,但其在肺腺癌 (LUAD) 瘤微环境 (TME) 中的作用尚不清楚.
- 瘤相关巨细胞 (TAMs) 是TME的关键组成部分,影响癌症生长和转移.
研究的目的:
- 调查S100P在LUAD TME中的作用,特别是它对TAM招募和两极分化的影响.
- 阐明S100P影响TAM和LUAD进展的分子机制.
主要方法:
- 在LUAD患者的组织免疫光分析.
- 对患者生存数据的生物信息学分析.
- 皮下小鼠模型的LUAD.
- 在体外研究的LUAD细胞涉及路径激活和抑制.
主要成果:
- S100P 特别表达在 LUAD 瘤细胞上,与 TAM 招募和 M2 极化相关.
- 高S100P表达与LUAD患者的整体存活率较差有关.
- S100P激活了LUAD细胞中的PKA/c-Jun通路,增强了招募和两极化TAM到M2表型的因素的分泌.
结论:
- 通过PKA/c-Jun信号通路,S100P通过招募M2 TAM来促进LUAD的增长.
- S100P显示出作为肺腺癌的诊断标记物和治疗点的潜力.
更多相关视频
11:01Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
Published on: August 24, 2021
2.8K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
